Brief: Olema Oncology Announces New Clinical Trial Collaboration And Supply Agreement With Novartis In Frontline Metastatic Breast Cancer As Well As $250 Million Equity Private Placement

Olema Oncology

02/12/2024 12:04

Dec 2 (Reuters) - Olema Pharmaceuticals  OLMA.O :
    * OLEMA ONCOLOGY ANNOUNCES NEW CLINICAL TRIAL COLLABORATION
AND
SUPPLY AGREEMENT WITH NOVARTIS IN FRONTLINE METASTATIC BREAST
CANCER AS WELL AS $250 MILLION EQUITY PRIVATE PLACEMENT
    * OLEMA PHARMACEUTICALS INC - WELL CAPITALIZED TO FUND
OPERATIONS
BEYOND KEY MILESTONES

Source text:  ID:nGNX5SNQcx 
Further company coverage:  OLMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))